<DOC>
	<DOCNO>NCT00134888</DOCNO>
	<brief_summary>Buprenorphine , treatment opioid dependence , mixed naloxone , limit abuse potential . The purpose study examine effectiveness buprenorphine/naloxone give less daily interval , order prevent withdrawal symptom associate stop opioid abuse .</brief_summary>
	<brief_title>Blockade Efficacy Buprenorphine/Naloxone For Opioid Dependence</brief_title>
	<detailed_description>Buprenorphine naloxone often combined decrease withdrawal symptom opioid dependent individual . Buprenorphine/naloxone usually give daily individual attempt stop opioid abuse ; however , research suggest individual may incline take medication give less daily interval . The purpose study examine opioid blockade effect buprenorphine/naloxone administer less daily dos opioid dependent individual . This study last 11 week . Participants stay residential research unit duration study . Participants randomly assign receive different dos daily , sublingual buprenorphine/naloxone . After minimum 2 week dose , participant undergo challenge session weekday 1 week ( Monday Friday ) . Challenge session consist increase dos intramuscular hydromorphone . During challenge session week , buprenorphine/naloxone give Monday ; placebo give rest week . Challenge session examine blockade effect buprenorphine/naloxone 2 , 26 , 50 , 74 , 98 hour last active dose buprenorphine/naloxone .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<criteria>Meets diagnostic criterion opioid dependence Qualifies opioid substitution treatment ( e.g. , methadone ) Significant psychiatric physical disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Opioid Dependence</keyword>
</DOC>